Clinical Trial Update: An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical Devices for the Treatment of Participants With Cardiac Arrhythmias

View source ↗

Summary

An observational post-marketing study using Biosense Webster medical devices to treat people with cardiac arrhythmias is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrhythmias

Snippet

Sponsor: Biosense Webster, Inc. | Conditions: Arrhythmias, Cardiac | Status: RECRUITING